According to Gram Research analysis, community-dwelling older adults with dementia took significantly more medications during their final year of life than other groups, with 50.9% experiencing polypharmacy (five or more drugs) and 8.7% experiencing hyperpolypharmacy (10 or more drugs). Despite medical guidelines recommending that doctors reduce unnecessary medications near the end of life, the most common drugs remained unchanged throughout the final year, suggesting deprescribing is not happening as recommended.

A new Canadian study looked at how many medications older adults take during their final year of life. Researchers compared three groups: people with dementia living at home, people without dementia living at home, and people with dementia in nursing homes. They found that people with dementia living in the community took the most medications, even though doctors should be reducing unnecessary drugs when someone is near the end of life. The study suggests that doctors and pharmacists need better strategies to stop prescribing medications that may no longer help.

Key Statistics

A 2026 case-control study of 3,822 older adults in Nova Scotia found that 50.9% experienced polypharmacy and 8.7% experienced hyperpolypharmacy during their final year of life, with community-dwelling dementia patients having the highest rates.

Among people in their final year of life, the most commonly prescribed medications were furosemide, levothyroxine sodium, salbutamol, and vitamin B12, and these remained the most common throughout all three time periods studied, suggesting deprescribing guidelines were not being followed.

Community-dwelling older adults with dementia consistently had higher rates of polypharmacy and hyperpolypharmacy compared to community-dwelling older adults without dementia and those with dementia in long-term care across all periods of the final year of life.

The Quick Take

  • What they studied: How many medications older adults with and without dementia were taking during their last year of life, and whether doctors were reducing unnecessary medications as recommended.
  • Who participated: Three groups of 1,274 people each (3,822 total) in Nova Scotia, Canada. All were older adults with an average age of 84.8 years who died between 2019 and 2021. One group had dementia and lived at home, one had dementia and lived in nursing homes, and one did not have dementia and lived at home.
  • Key finding: About half of all participants (50.9%) took many medications at once, called polypharmacy. People with dementia living at home had the highest rates of taking multiple medications throughout their final year, even though this is not recommended for end-of-life care.
  • What it means for you: If you or a loved one with dementia is nearing the end of life, it may be worth asking doctors whether all prescribed medications are still necessary. Some drugs meant to prevent future health problems may not help when someone is very ill and should be stopped. This finding suggests doctors need better support in making these difficult decisions.

The Research Details

Researchers used a case-control study design, which means they compared groups of people with different characteristics to understand what factors affect medication use. They looked back at health records from Nova Scotia, Canada, for people who died between January 2019 and January 2021. They matched three groups by age, sex, and date of death so the groups would be as similar as possible except for dementia status and living situation.

The study divided the final year of life into three equal time periods: early (months 12 to 8 before death), middle (months 8 to 4 before death), and late (months 4 to 0 before death). This allowed researchers to see if medication patterns changed as people got closer to the end of life. They counted how many medications each person was taking and looked at which specific drugs were most commonly prescribed.

Researchers used statistical methods to account for other factors that might affect medication use, such as age and other health conditions. This helps ensure that differences between groups were due to dementia status rather than other reasons.

This research approach is important because it uses real-world health records rather than relying on what people remember or report. By matching groups carefully, researchers could focus on how dementia and living situation affect medication use rather than other factors. Looking at three time periods during the final year shows whether medication patterns actually change as people approach death, which is crucial for understanding whether current practices match medical guidelines.

This study has several strengths: it used a large sample size (3,822 people), included real health data from an entire province, and carefully matched groups to make fair comparisons. The study was published in a peer-reviewed medical journal, meaning other experts reviewed it before publication. However, the study only included people from Nova Scotia, so results may not apply to other regions with different healthcare systems. The study also could not determine why doctors prescribed certain medications, so we cannot know if there were good reasons for the high medication use.

What the Results Show

The study found that polypharmacy, which means taking five or more medications at once, was very common in the final year of life. Overall, 50.9% of all participants experienced polypharmacy. Even more concerning, 8.7% experienced hyperpolypharmacy, which means taking 10 or more medications at once. Community-dwelling older adults with dementia had the highest rates of polypharmacy and hyperpolypharmacy across all three time periods studied.

The most commonly prescribed medications in the final year of life were furosemide (a water pill), levothyroxine sodium (a thyroid hormone), salbutamol (an asthma inhaler), and vitamin B12. These medications remained the most common throughout the entire final year, even in the last few months of life. This pattern is important because it suggests that doctors were not reducing medications as recommended by medical guidelines for end-of-life care.

When researchers compared the three groups, community-dwelling people with dementia consistently had higher rates of taking multiple medications than the other two groups. This was true in the early period of the final year, the middle period, and the late period. The difference was most striking for hyperpolypharmacy, where community-dwelling dementia patients had the highest rates.

The study found that medication patterns did not change much across the three time periods of the final year. This is significant because medical guidelines recommend that as people approach death, doctors should stop medications that prevent future diseases (like cholesterol medications or blood pressure pills) and focus only on comfort medications. The fact that the same medications remained most common throughout suggests this deprescribing process was not happening regularly. The study also noted that the types of medications prescribed did not shift toward comfort-focused drugs as people got closer to death.

This research adds to growing evidence that polypharmacy is common at the end of life and that deprescribing (stopping unnecessary medications) is not happening as often as medical guidelines recommend. Previous research has shown that taking too many medications can cause harm, especially in older adults and people with dementia. This study is one of the first to specifically examine whether medication patterns change during the final year of life in people with dementia, making it a valuable addition to the research on end-of-life care.

This study only included people from Nova Scotia, Canada, so the results may not apply to other countries or regions with different healthcare systems. The study could not determine why doctors prescribed certain medications or whether there were medical reasons for the high medication use. The researchers also could not know whether patients or families wanted to reduce medications or whether doctors discussed deprescribing with them. Additionally, the study looked back at past records, so it could not control for all factors that might have influenced prescribing decisions.

The Bottom Line

For people with dementia nearing the end of life, have a conversation with doctors about which medications are still necessary. Ask specifically about stopping medications meant to prevent future diseases, such as cholesterol or blood pressure medications, since these may not help someone who is very ill. Instead, focus on medications that provide comfort. Pharmacists can play an important role in reviewing medications and recommending which ones to stop. This recommendation has moderate confidence because the study shows current practice does not match guidelines, but individual cases may vary.

This research matters most for families of people with dementia, doctors and nurses who care for dying patients, and pharmacists. It is especially relevant for people with dementia living in the community, who showed the highest medication use. Healthcare systems and policymakers should care about this because it suggests training and support for doctors and pharmacists could improve end-of-life care. People without dementia and those in nursing homes may benefit less from these specific findings, though the general principle of reducing unnecessary medications applies to all end-of-life care.

Changes in medication use can happen quickly once doctors and patients decide to deprescribe. Some medications can be stopped immediately, while others need to be reduced gradually over days or weeks to avoid side effects. Patients and families should expect conversations about medication changes to happen well before the very end of life, ideally months in advance, so there is time to adjust and monitor how the person feels.

Frequently Asked Questions

Should medications be stopped when someone with dementia is dying?

Medical guidelines recommend stopping medications that prevent future diseases (like cholesterol pills) when someone is near the end of life, since these do not provide comfort. Continue only medications that relieve pain, difficulty breathing, or other distressing symptoms. Discuss this with doctors well in advance.

What is polypharmacy and why is it a problem at the end of life?

Polypharmacy means taking five or more medications at once. At the end of life, too many medications can cause confusion, falls, nausea, and other side effects that reduce comfort. Older adults with dementia are especially vulnerable to these harmful effects.

How common is taking too many medications in the final year of life?

A 2026 Canadian study found that about half of older adults (50.9%) took five or more medications during their final year of life. Community-dwelling people with dementia had even higher rates, suggesting this is a widespread issue in end-of-life care.

What can families do if their loved one is taking too many medications?

Ask the doctor or pharmacist to review all medications and explain why each one is necessary. Request a medication deprescribing plan that stops preventive drugs and focuses on comfort. Get this conversation in writing and share it with all healthcare providers involved in care.

Do nursing home residents take fewer medications than people living at home with dementia?

Yes, according to this study, community-dwelling older adults with dementia had higher rates of polypharmacy than those in long-term care facilities. This suggests nursing homes may have better medication review processes or different prescribing practices.

Want to Apply This Research?

  • Track the number of medications taken daily and note which ones are for prevention versus comfort. Create a simple list showing medication name, dose, and purpose. Update this list monthly and share it with healthcare providers to identify medications that could be stopped.
  • Use the app to schedule a medication review conversation with your doctor or pharmacist. Set a reminder to ask specifically about stopping preventive medications if you or your loved one is in the final year of life. Document which medications were discussed for potential discontinuation and follow up on the decision.
  • Track changes in medication count over time using the app’s trending feature. Monitor for side effects or problems that might result from taking too many medications, such as confusion, falls, or nausea. Share monthly medication reports with healthcare providers to ensure deprescribing recommendations are being followed and adjusted as needed.

This research describes patterns of medication use in people with dementia near the end of life and does not provide medical advice. Medication decisions should always be made in consultation with qualified healthcare providers who know the individual’s complete medical history and current condition. Do not stop, start, or change any medications without discussing with a doctor or pharmacist first. This study was conducted in Canada and may not apply to all healthcare systems or populations. If you have concerns about medications for yourself or a loved one, speak with your healthcare team immediately.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Polypharmacy and patterns of medication use in the final year of life among people living with dementia in Canada: A case-control study. , The Journal of international medical research (2026). PubMed 42802178 | DOI
Topics
polypharmacy end of life dementia medication management deprescribing elderly patients too many medications seniors end of life care medications dementia palliative care medication review older adults hyperpolypharmacy